Advertisement

The Role of FDG PET/CT in the Investigation of Pyrexia of Unknown Origin

  • Tehmina Bharucha
  • Thomas Wagner
  • Deborah Pencharz
Chapter
Part of the Clinicians’ Guides to Radionuclide Hybrid Imaging book series (CGRHI)

Abstract

A critical appraisal of the role of FDG PET in Pyrexia of Unknown Origin (PUO) depends on an understanding of current concepts of PUO and systematic review of available evidence. This chapter provides an introduction to case definitions of PUO and summarises the current evidence, reviews available guidelines and discusses limitations in the application of FDG PET/CT for investigation of PUO.

References

  1. 1.
    Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine (Baltimore). 1961;40:1–30.CrossRefGoogle Scholar
  2. 2.
    Knockaert DC, Vanderschueren S, Blockmans D. An evidence-based approach to fever of unknown origin. Arch Intern Med. 2003;163(16):1976–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Bleeker-Rovers CP, Vos FJ, de Kleijn EM, Mudde AH, Dofferhoff TS, Richter C, et al. A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine. 2007;86(1):26–38.CrossRefPubMedGoogle Scholar
  4. 4.
    Bharucha T, Cockbain B, Brown M. Pyrexia of unknown origin: revisiting concepts to reflect on current clinical practice. Br J Hosp Med. 2016;77:579–83.CrossRefGoogle Scholar
  5. 5.
    Mourad O, Palda V, Detsky AS. A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med. 2003;163(5):545–51.CrossRefPubMedGoogle Scholar
  6. 6.
    Gaeta GB, Fusco FM, Nardiello S. Fever of unknown origin: a systematic review of the literature for 1995-2004. Nucl Med Commun. 2006;27(3):205–11.CrossRefPubMedGoogle Scholar
  7. 7.
    Naito T, Mitsumoto F, Morita H, Mizooka M, Oono S, Ukimura A, et al. A multi-institution retrospective study on causative diseases and diagnostic methods for fevers of unknown origin in Japan: A project of the japanese society of general hospital medicine. J Gen Intern Med. 2013;28:S10.Google Scholar
  8. 8.
    Vaidyanathan S, Patel CN, Scarsbrook AF, Chowdhury FU. FDG PET/CT in infection and inflammation–current and emerging clinical applications. Clin Radiol. 2015;70(7):787–800.CrossRefPubMedGoogle Scholar
  9. 9.
    Bharucha T, Rutherford A, Skeoch S, Alavi A, Brown M, Galloway J. Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis and Delphi exercise. Clin Radiol. 2017;72:764–71.CrossRefPubMedGoogle Scholar
  10. 10.
    Boellaard R, Delgado-Bolton R, Oyen WJG, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54.CrossRefPubMedGoogle Scholar
  11. 11.
    Buscombe J. Guidelines for the use of F-18-FDG in infection and inflammation: a new step in cooperation between the EANM and SNMMI. Eur J Nucl Med Mol Imaging. 2013;40(7):1120–1.CrossRefPubMedGoogle Scholar
  12. 12.
    RCP/RCR/BSNM. Evidence-based indications for the use of PET-CT in the UK 2013; 2013.Google Scholar
  13. 13.
    Dibble EH, Yoo DC, Noto RB. Role of PET/CT in workup of fever without a source. Radiographics. 2016;36(4):1166–77.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Tehmina Bharucha
    • 1
  • Thomas Wagner
    • 2
  • Deborah Pencharz
    • 3
  1. 1.University College London and Royal Free Hospital LondonLondonUK
  2. 2.Department of Nuclear MedicineRoyal Free London NHS Foundation TrustLondonUK
  3. 3.Department of Nuclear MedicineBrighton and Sussex University Hospitals NHS Trust, Royal Sussex County HospitalBrightonUK

Personalised recommendations